Ocular Therapeutix Inc (NASDAQ:OCUL) price on Wednesday, July 02, rose 3.96% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $9.46.
A look at the stock’s price movement, the close in the last trading session was $9.1, moving within a range at $9.04 and $9.595. The beta value (5-Year monthly) was 1.406. Turning to its 52-week performance, $11.77 and $5.78 were the 52-week high and 52-week low respectively. Overall, OCUL moved 16.65% over the past month.
Ocular Therapeutix Inc’s market cap currently stands at around $1.51 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-May-05.
Turning to the stock’s technical picture we see that short term indicators suggest on average that OCUL is a 100% Buy. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend OCUL as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
OCUL’s current price about 6.98% and 16.30% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 63.56, while 7-day volatility ratio is 5.78% and 6.03% in the 30-day chart. Further, Ocular Therapeutix Inc (OCUL) has a beta value of 1.48. Analysts have given the company’s stock an average 52-week price target of $19, forecast between a low of $19 and high of $19. Looking at the price targets, the low is -100.85% off current price level while to achieve the yearly target high, price needs to move -100.85%. Nonetheless, investors will most likely welcome a -100.85% jump to $19 which is the analysts’ median price.
If we refocus on Ocular Therapeutix Inc (NASDAQ:OCUL), historical trading data shows that trading volumes averaged 2.71 over the past 10 days and 2.13 million over the past 3 months. The company’s latest data on shares outstanding shows there are 159.26 million shares.
The 16.33% of Ocular Therapeutix Inc’s shares are in the hands of company insiders while institutional holders own 74.32% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 14.42 million on 2025-06-13, giving us a short ratio of 5.95. The data shows that as of 2025-06-13 short interest in Ocular Therapeutix Inc (OCUL) stood at 909.0000400000001 of shares outstanding, with shares short rising to 13.83 million registered in 2025-05-15. Current price change has pushed the stock 38.30% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the OCUL stock continues to rise going into the next quarter.
